Who Just Raised
Get Pro

Oakdale, MN · Health Care · Form D filed Oct 14, 2026

InSitu Biologics, Inc. raised $1.3M

InSitu Biologics, Inc. is a biotechnology company based in Oakdale, Minnesota. In an amended Form D filed with the SEC on October 14, 2026, it reported raising $1,250,000 from 1 investor as part of an offering of up to $3,375,000. The first sale in the offering took place on August 4, 2026.

InSitu Biologics is advancing localized sustained-release drug delivery, starting with INSB200™, a peripheral nerve block for extended post-surgical pain relief.

$13.2M raised since 2020

4 Form D offerings, as reported to the SEC, the first in Feb 25, 2021. Amendments update a round; they aren't counted twice.

FiledSoldOffering sizeInvestors
Aug 10, 2026$1.3M$3.4M1
Dec 18, 2025$4M$8M29
Dec 29, 2023$3M$3M1
Feb 25, 2021$5M$5.5M22

Lead score

39 out of 100

filed this week still raising budget to spend website found

Outreach kit How it works 1:21

A first message that shows you did your homework, written from this filing. Fill in the brackets and send.

Email · subject: Congrats on the new round

Hi [first name],

Congrats on the new round. I saw the raise in your SEC filing.

Teams at this stage usually start looking at [what you do] right after a round...

[Your name]

LinkedIn note

Congrats on the new round. I work with [who you help] on [what you do] right after a raise. Open to connecting?

Call opener

Hi, this is [your name] from [company]. I am calling because you just filed a raise with the SEC...

Find the right person Founders & CEO · Finance · Operations · People & hiring · Sales & marketing

Track this company How it works 0:56

Saved to your dashboard pipeline, with a badge in Explore.

Loading your outreach kit…

The outreach kit is part of Pro. Copy-ready email, LinkedIn and call openers for every new raise, plus daily alerts for the companies you sell to.

Start your free trial Already on Pro? Sign in

Filing details

Website
insitubiologics.com
Amount raised
$1,250,000
Offering size
$3,375,000
Investors so far
1
Minimum investment
$2,500,000
First sale
August 4, 2026
Securities offered
Debt, Options or warrants, Other
Exemption claimed
Rule 506(b)
Industry
Biotechnology
Headquarters
Oakdale, Minnesota
Incorporated
Delaware
Entity type
Corporation

Filings

FiledFormRaisedOffering sizeInvestorsSource
D/A (amendment) $1,250,000 $3,375,000 1 SEC filing
D (new notice) $1,250,000 $2,500,000 1 SEC filing

Figures come from the company's own filings with the SEC and are shown as reported. The first notice for this offering was filed on August 10, 2026. How to read a Form D.

Updated · Raises in the week of Aug 10, 2026 · Health Care funding in Minnesota · August 2026 funding report

Health CareNo press found $7.5M

Vireo Growth Inc.

Minneapolis, MN · filed Oct 7

Vireo Growth, Inc.'s mission is to provide safe access, quality and value to its customers while supporting its communities through active participation and restorative justice programs. The Company…

17th Form D since 2019

Health Care $10.5M

Piraeus Medical, Inc.

Rochester, MN · filed Oct 7

11th Form D since 2022Still raising

Health Care $520K

Pelvital USA, Inc.

Eagan, MN · filed Oct 5

8th Form D since 2020Still raising

Health Care $5.5M

Evia Bio, Inc.

Minneapolis, MN · filed Sep 28

Evia Bio’s cryopreservation technology enables the entire Cell Therapy supply chain with high product yield, efficacy, and safety. You don’t have to settle for less.

First Form D

Health Care $30K

Pelva Health Corp

Edina, MN · filed Aug 7

2nd Form D since 2024Still raising

Who Just Raised Pro

The raises that matter to you, in your inbox every weekday morning.

Your sectors, states and deal size · first-time vs repeat raisers · open rounds · a watchlist · every raise as a spreadsheet each Monday.